值得注意的是，这一监管态势的强化，意味着监管的聚光灯如今更为集中地照向了资本市场 的另一核心"看门人"——会计师事务所。 2026年伊始，资本市场监管的重点正出现新动向。一系列密集的监管行动勾勒出一幅清晰的 图景：会计师事务所正成为当前强化中介机构责任的焦点。 21世纪经济报道记者根据证监会及各地证监局官网梳理发现， 在今年1月1日至2月9日的40天 内，证监系统已累计点名22家会计师事务所 ，监管行动呈现高频、强力态势。其中，中兴 华、中兴财光华、利安达所3家机构收到了更为严厉的行政处罚决定书；与此同时，共有21家 机构收到警示函，相当于平均每两天就有一家被出具警示函。 4 0天2 2家！会计所监管强度陡增 在业内人士看来，此举旨在通过压实审计责任，从信息源头进一步保障上市公司质量，推动 市场生态的持续净化。伴随会计所合规意识的加强与历史问题的出清，经历一段时间的罚单 集中披露后，后续被点名的会计所数量大概率将逐步减少。 在2026年1月1日至2月9日的短短40天内，已有22家会计师事务所被证监会及各地证监局点 名。 其中，中兴华所、 中兴财光华所、利安达所 被出具行政处罚决定书，这几乎是证监系统能够 对会 ...

Core Viewpoint - Investors have won a first-instance victory in a lawsuit against Luopute Securities for false statements, indicating that similar cases will likely receive quicker judgments in the future [1][4]. Group 1: Legal Proceedings - The Shanghai Huzhi Law Firm has submitted a batch of cases to the court and is currently gathering affected investors [1][4]. - The lawsuit stems from a penalty received by the company in October 2023, where it was found to have falsified annual reports, violating the Securities Law and harming investor interests [1][4]. - Investors who purchased shares between April 20, 2021, and May 17, 2023, and sold or still hold shares after May 18, 2023, can join the lawsuit for compensation [1][4]. Group 2: Compensation Claims - The administrative penalty decision revealed that the company had signed three supply agreements with a total contract value of 242 million yuan in December 2020 [2][4]. - In 2021, the company and its wholly-owned subsidiary signed three supply agreements for six projects in Jiangsu Province and one project in Guizhou Province, with a total contract value of 149 million yuan [2][4]. - The company recognized revenue based on the delivery and acceptance by customers, but the control of the goods had not transferred to the customers at the time of revenue recognition, leading to false financial statements [5]. Group 3: Auditor Accountability - The case also implicates the auditing firm, Shanggong, which failed to perform due diligence during the audits of Luopute's financial statements for 2021 and 2022, resulting in false records [2][5]. - If Shanggong cannot prove its lack of fault, it may be held jointly liable for compensation alongside Luopute, providing investors with additional avenues for recovery [5].

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、投资者获得一审胜诉 据公开消息，部分投资者诉罗普特（维权）证券虚假陈述案已迎来新进展，法院已对本案示范性案件作 出判决，投资者获得一审胜诉。（刘鹏律师专栏） 这一判决标志着罗普特索赔案件取得了关键性进展，为后续大规模投资者索赔奠定了积极的法律基础。 其被起诉事起于2023年收到的一则处罚，2023年10月31日公司公告收到厦门证监局下发的《行政处罚决 定书》。该公司相关年报存在造假，此类行为严重破坏市场运行基础，侵害投资者利益的行为，根据 《证券法》及虚假陈述若干规定，因其虚假陈述行为造成损失的投资者可提起民事诉讼，要求其赔付投 资损失。 此次胜诉意味着后续同类型案件也将获得更快判决，投资者可放心参与。上海沪紫律师事务所刘鹏律师 团队现仍在征集受损投资者中。 （本文由上海沪紫律师事务所刘鹏律师供稿，不代表新浪财经的观点。刘鹏律师，专注证券维权19年， 自2006年执业以来，成功为中青宝、国华网 ...

Core Viewpoint - The Shanghai Financial Court ruled on the bond issuance false statement case involving Shanghai Huaxin International Group, determining that five institutions share 14.5% of the liability for the plaintiff's loss of 128 million yuan, amounting to over 18.56 million yuan [3][14]. Summary by Sections Case Background - The bonds in question were issued by Shanghai Huaxin in 2017, with a total issuance amount of 2.5 billion yuan and a coupon rate of 7.5% [3]. - The total amount of bonds issued by the issuer from 2014 to 2017 exceeded 40 billion yuan, indicating the case's significant scale and the number of affected investors [3]. Legal Proceedings - The focus of the dispute included whether Shanghai Huaxin engaged in false statements, the materiality of such statements, and the relationship between the plaintiff's investment losses and these statements [5]. - The court found that Shanghai Huaxin had concealed numerous related parties and failed to disclose significant related transactions, which severely impacted investors' judgment regarding the company's financial health [9][10]. Evidence and Investigation - The plaintiff's legal team undertook extensive investigations, analyzing bond prospectuses and related transactions to establish evidence of false statements [6]. - The complexity of the corporate structure of Shanghai Huaxin, with over 70 associated companies, posed challenges in tracing the relationships and transactions [6][7]. Court's Findings - The court recognized that the issuer had hidden at least 29 related parties and misrepresented transaction amounts, which constituted significant false statements [9]. - The court set March 1, 2018, as the disclosure date, coinciding with media reports about the investigation of the actual controller of Huaxin [10]. Loss Assessment - A third-party expert opinion was commissioned to assess the losses incurred by investors, distinguishing between losses due to false statements and those from other factors [11]. - The assessment concluded that approximately 1.28 billion yuan of the total losses were attributable to false statements, with a detailed breakdown of the contributing factors to the bond price decline [12][13]. Implications for Investor Rights - The ruling sets a precedent for investor claims in cases of false statements without prior regulatory investigations, providing a new avenue for investor protection [16]. - The case highlights the importance of establishing recognized standards for loss assessment models to ensure judicial credibility and consistency in similar cases [15].

Core Points - The Shanghai Huaxin International Group Co., Ltd. case involves significant financial implications and numerous investors, with a trial period exceeding three years, raising industry-wide concerns regarding the responsibilities of intermediary institutions [1] - On October 28, the Shanghai Financial Court issued a first-instance judgment in the case of false statements related to Huaxin's bond issuance, holding five institutions liable for a total of 14.5% of the plaintiff's losses, amounting to over 18.56 million yuan [1][11] - The bonds in question were issued in 2017, with a total issuance amount of 2.5 billion yuan and a coupon rate of 7.5%, while the issuer, Huaxin, has already been declared bankrupt by the court [1][11] Summary by Sections Case Background - The case involves a total bond issuance exceeding 40 billion yuan from 2014 to 2017, with significant implications for similar cases in the industry [1] - The focus of the dispute includes whether Huaxin made false statements, the materiality of such statements, and the relationship between these statements and the plaintiff's investment losses [2] Evidence and Legal Proceedings - The plaintiff's legal team undertook extensive research to establish evidence of false statements, examining bond prospectuses and related transactions [3] - The complexity of Huaxin's corporate structure, with over 70 associated companies, complicates the identification of false statements [3] Court Findings - The court recognized that Huaxin failed to disclose numerous related party transactions, significantly impacting investors' assessments of the company's financial health [6] - The court set March 1, 2018, as the disclosure date, coinciding with media reports about the investigation of Huaxin's actual controller [6] Loss Assessment - A third-party expert was commissioned to assess the losses incurred by the plaintiff, distinguishing between losses due to false statements and those from other factors [7][8] - The expert opinion indicated that the total loss for investors was approximately 232 million yuan, with about 128 million yuan attributed to false statements [11] Implications for Investor Rights - The judgment opens new avenues for investor claims against intermediary institutions, marking a significant development in the protection of investor rights [12] - The case sets a precedent for future litigation involving false statements in bond issuance, particularly in the absence of regulatory investigations [12]

Core Viewpoint - The Shanghai Financial Court ruled on a case involving false statements in bond issuance documents by Shanghai Huaxin International Group, marking the first securities false statement liability dispute in the interbank bond market [1][4]. Group 1: Case Background - The case originated from a rural commercial bank suing various intermediary institutions, including underwriters and rating agencies, for compensation due to false statements in bond issuance [1]. - The total amount of bonds issued by Shanghai Huaxin from 2014 to 2017 exceeded 40 billion yuan [1]. - The plaintiff, a rural commercial bank, invested over 200 million yuan, and multiple investment institutions have sued Shanghai Huaxin due to bond defaults [1]. Group 2: Court Ruling - The court determined that five intermediary institutions must bear joint liability for the losses incurred by the plaintiff, amounting to approximately 128 million yuan [4]. - Postal Savings Bank and China International Capital Corporation are each responsible for 5% of the losses, equating to about 6.39 million yuan [2]. - Other intermediaries, including accounting firms and credit rating agencies, are liable for smaller percentages of the losses, totaling approximately 2.1 million yuan [2]. Group 3: Loss Assessment - The court acknowledged the complexity of factors leading to investment losses, including macroeconomic conditions and the investigation of the actual controller of the issuing company [3]. - A third-party professional institution was commissioned to assess the losses, employing methods aligned with bond pricing principles and market characteristics [3]. - The assessment distinguished losses across three phases: from issuance to disclosure, from disclosure to default, and from default to bankruptcy ruling [3].

Core Viewpoint - The Shanghai Financial Court ruled on a case involving false statements in bond issuance by Shanghai Huaxin International Group, marking a significant precedent in the interbank bond market regarding securities fraud liability [1][2][4] Group 1: Case Background - The case involves a rural commercial bank suing various intermediary institutions for compensation due to false statements in bond issuance documents by Shanghai Huaxin, which issued over 40 billion yuan in bonds from 2014 to 2017 [1][2] - The plaintiff, a rural commercial bank, invested over 200 million yuan in the bonds, which subsequently defaulted [2][3] Group 2: Court Ruling - The court determined that five intermediary institutions, including Postal Savings Bank and CICC, are liable for a total loss of approximately 128 million yuan, with specific percentages of liability assigned to each [2][4] - The ruling specified that the defendants must bear joint liability for the losses, with Postal Savings Bank and CICC responsible for 5% each, while other intermediaries have lower percentages [2][4] Group 3: Loss Assessment Methodology - The court commissioned a third-party professional agency to assess the losses caused by non-fraudulent statements, utilizing the "bond value comparison method" and considering various factors such as macroeconomic conditions and the issuer's operational status [3][4] - The assessment was divided into three phases: from issuance to disclosure, from disclosure to default, and from default to bankruptcy ruling, ensuring a comprehensive evaluation of the losses [3]

Core Viewpoint - The company, Hongbo Co., Ltd. (002229.SZ), announced a change in its auditing firm for the fiscal year 2025, moving from Shanhui Accounting Firm to Zhongxinghua Accounting Firm to ensure the independence and objectivity of the audit process [1] Group 1: Audit Change - The company has communicated with both the outgoing and incoming auditing firms, and both parties have no objections to the change [1] - The decision to change auditors is based on considerations of future business development and overall audit needs [1] Group 2: Audit Opinion - The previous auditor, Shanhui Accounting Firm, issued a qualified opinion on the company's 2024 financial report, primarily concerning the valuation of equipment worth 633 million yuan from its wholly-owned subsidiary, Beijing Yingbo Shuke Technology Co., Ltd. [1] - The qualified opinion arose because the auditing firm could not perform monitoring procedures on the equipment due to confidentiality issues, and some confirmations were not received, leading to insufficient audit evidence regarding the equipment's specifications, quantity, value, and condition [1] - The company stated that acceptance reports or delivery receipts for the equipment were obtained from customers between March and April 2025, confirming the brand, model, and quantity of the equipment [1] - The board of directors acknowledged that the audit opinion objectively reflects the company's financial status and internal control situation, and the company is taking the non-standard opinion seriously, with some issues already resolved [1]

Group 1 - The company has approved the appointment of an accounting firm for the special audit related to the issuance of A-shares in 2025 [1] - The board has also approved providing guarantees for its subsidiary, Guofa Pharmaceutical, which is seeking a loan of 20 million yuan from Postal Savings Bank [1] - Guofa Pharmaceutical aims to achieve sales revenue of no less than 381 million yuan in 2025 and is focused on turning losses into profits [1] Group 2 - The company has not disclosed the timeline or purpose for the upcoming capital increase, but it may strengthen its core business and explore new areas such as artificial intelligence [2] - The company plans to enhance the brand marketing of its "Haibao" eye drops, which is in a growing market, by increasing R&D investment and building automated production lines [2] - The chairman has recently visited a leading cloud-native operating system company, indicating potential new business expansion ideas [2]

Core Insights - Guofa Co., Ltd. (600538) has announced the appointment of a special auditing firm for a simplified procedure to issue A-shares to specific investors, with a total financing amount not exceeding 300 million yuan [1] - The company is focused on the health sector, covering pharmaceutical manufacturing, distribution, and IVD (in vitro diagnostics) [1] - A new diversified executive team has been established, including Chairman Jiang Ye and President Zhang Xiaowei, to drive the company's new development strategy [1] Company Developments - The IVD industry is transitioning from "single testing" to "precision and full-cycle management," with companies having core technological breakthroughs and global integration advantages becoming more competitive [1] - Guofa's subsidiary, Gao Sheng Bio, has developed an ultra-micro DNA automatic extraction workstation, enhancing automation in sample preparation and achieving success in forensic DNA second-generation sequencing library construction [1] - The company plans to focus on brand marketing for its eye drop product "Haibao" this year, which is recognized as a key technological innovation project and included in the national medical insurance and essential drug list [2] Strategic Initiatives - In late July, Chairman Jiang Ye led a visit to DaoKe Technology, a leading cloud-native operating system company, signaling the company's exploration into the AI field [2]